Organization | SVS Institute of Dental Sciences

SVS Institute of Dental Sciences Report issue

Academic/Hospital Phase 1 Phase 2

Founded: Mahabubnagar India (2003)

Organization Overview

First Clinical Trial

2012

NCT02043340

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

SVS Institute of Dental Sciences

Active Ingredients

Drugs in Phase 2 Trials (7)

alveograf (1 trial)

bone morphogenetic protein-2 (3 trials)

curcumin (1 trial)

indocyanine green (ic-green) (1 trial)

silicon phthalocyanine (1 trial)

siloss (1 trial)

stevia (1 trial)

Drugs in Phase 1 Trials (2)

epidermal growth factor (1 trial)

trafermin (1 trial)

Drugs in Other Trials (1)

ursodeoxycholic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alveolar Bone Loss (Phase 2)

Chronic Periodontitis (Phase 2)

Fibrosis (Phase 2)

Gingival Recession (Phase 1)

Malocclusion (Phase 2)

Oral Submucous Fibrosis (Phase 2)

Periodontitis (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 11
# of Trial APIs: 10